These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

142 related items for PubMed ID: 3298360

  • 1. Anisoylated plasminogen streptokinase activator complex in acute myocardial infarction: a placebo-controlled arteriographic coronary recanalization study.
    Timmis AD, Griffin B, Crick JC, Sowton E.
    J Am Coll Cardiol; 1987 Jul; 10(1):205-10. PubMed ID: 3298360
    [Abstract] [Full Text] [Related]

  • 2. An interim report of a double-blind placebo-controlled recanalisation study of anisoylated plasminogen streptokinase activator complex in acute myocardial infarction.
    Timmis AD, Griffin B, Crick JC, Flax JS, Sowton E.
    Drugs; 1987 Jul; 33 Suppl 3():146-50. PubMed ID: 3315582
    [Abstract] [Full Text] [Related]

  • 3. Multicenter trial of intravenous anisoylated plasminogen streptokinase activator complex (APSAC) in acute myocardial infarction: effects on infarct size and left ventricular function.
    Bassand JP, Machecourt J, Cassagnes J, Anguenot T, Lusson R, Borel E, Peycelon P, Wolf E, Ducellier D.
    J Am Coll Cardiol; 1989 Apr; 13(5):988-97. PubMed ID: 2647817
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. Intravenous anisoylated plasminogen streptokinase activator complex versus intravenous streptokinase in evolving myocardial infarction. Preliminary data from a randomised multicentre study.
    Brochier ML, Quilliet L, Kulbertus H, Materne P, Letac B, Cribier A, Monassier JP, Sacrez A, Favier JP.
    Drugs; 1987 Apr; 33 Suppl 3():140-5. PubMed ID: 3315581
    [Abstract] [Full Text] [Related]

  • 7. Comparison of intravenous anisoylated plasminogen streptokinase activator complex and intracoronary streptokinase in acute myocardial infarction.
    Bonnier HJ, Visser RF, Klomps HC, Hoffmann HJ.
    Am J Cardiol; 1988 Jul 01; 62(1):25-30. PubMed ID: 3289357
    [Abstract] [Full Text] [Related]

  • 8. Early clinical evaluation of the intravenous treatment of acute myocardial infarction with anisoylated plasminogen streptokinase activator complex.
    Kasper W, Meinertz T, Wollschläger H, Bonzel T, Chen C, Hofmann T, Zeiher A, Drexler H, Just H.
    Drugs; 1987 Jul 01; 33 Suppl 3():112-6. PubMed ID: 3315575
    [Abstract] [Full Text] [Related]

  • 9. Reperfusion in acute myocardial infarction. A multicentre randomised trial of early intracoronary streptokinase and intravenous anisoylated plasminogen streptokinase activator complex in the United States.
    Anderson JL.
    Drugs; 1987 Jul 01; 33 Suppl 3():154-62. PubMed ID: 3315584
    [Abstract] [Full Text] [Related]

  • 10. Coronary thrombolysis during acute myocardial infarction by intravenous BRL 26921, a new anisoylated plasminogen-streptokinase activator complex.
    Kasper W, Meinertz T, Wollschläger H, Bonzel T, Wolff P, Drexler H, Hofmann T, Zeiher A, Just H.
    Am J Cardiol; 1986 Sep 01; 58(6):418-21. PubMed ID: 3529908
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. Anisoylated plasminogen streptokinase activator complex versus streptokinase in acute myocardial infarction. Preliminary results of a randomised study.
    Monnier P, Sigwart U, Vincent A, Bachmann F, Goy JJ, Schaller MD, Kaufmann U, Badan M, Grbic M, Perret C.
    Drugs; 1987 Sep 01; 33 Suppl 3():175-8. PubMed ID: 3315587
    [Abstract] [Full Text] [Related]

  • 15. Evaluation of 2 intravenous thrombolytic agents (anisoylated plasminogen streptokinase activator complex versus streptokinase) in patients with acute myocardial infarction.
    Seabra-Gomes R, Aniceto Silva J, Aleixo A, Real T, Freire I, Torres I, Freitas R, Crespo F.
    Drugs; 1987 Sep 01; 33 Suppl 3():169-74. PubMed ID: 3315586
    [Abstract] [Full Text] [Related]

  • 16. Development and evaluation of anisoylated plasminogen streptokinase activator complex (APSAC) as a second generation thrombolytic agent.
    Anderson JL.
    J Am Coll Cardiol; 1987 Nov 01; 10(5 Suppl B):22B-27B. PubMed ID: 3312369
    [Abstract] [Full Text] [Related]

  • 17. Reperfusion, patency and reocclusion with anistreplase (APSAC) in acute myocardial infarction.
    Anderson JL.
    Am J Cardiol; 1989 Jul 05; 64(2):12A-17A; discussion 24A-26A. PubMed ID: 2662737
    [Abstract] [Full Text] [Related]

  • 18. Rapid lysis of coronary artery thrombi with anisoylated plasminogen: streptokinase activator complex. Treatment by bolus intravenous injection.
    Marder VJ, Rothbard RL, Fitzpatrick PG, Francis CW.
    Ann Intern Med; 1986 Mar 05; 104(3):304-10. PubMed ID: 3511819
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. The German multicenter trial of anisoylated plasminogen streptokinase activator complex versus heparin for acute myocardial infarction.
    Meinertz T, Kasper W, Schumacher M, Just H.
    Am J Cardiol; 1988 Sep 01; 62(7):347-51. PubMed ID: 3046283
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 8.